Cure51 raises a €15M Seed round aiming to crack the code on cancer survival
Rather than grimly assembling data about cancer deaths to predict outcomes in treatment, the founders of Cure51 had another idea. They decided to turn the model around 180 degrees. Instead, the company assembles data about long term survivors of cancer, thus hoping to crack the code on what keeps people alive. It’s now raised a […]
© 2024 TechCrunch. All rights reserved. For personal use only.
